No Data
No Data
Guosen Securities: After the centralized procurement of IVD, the industry landscape has changed, and the assembly line has become a battleground.
In the environment of centralized procurement, having TLA products with low cost and high quality will become the core competitiveness of IVD companies.
Insiders Were the Key Beneficiaries as Shenzhen YHLO Biotech Co., Ltd.'s (SHSE:688575) Market Cap Rises to CN¥12b
Yahui Long (688575.SH): Obtained IVDR CE certification.
On September 6th, Guolonghui reported that Yahui Long (688575.SH) announced that the company has recently received the IVDR CE Class D certification issued by BSI Group The Netherlands B.V. The new European Union In Vitro Diagnostic Medical Devices Regulation (IVDR, EU 2017/746) has replaced the original European Union In Vitro Diagnostic Medical Devices Directive (IVDD, 98/79/EC) for the management of in vitro diagnostic medical devices in the European Union market.
2024 Semi-Annual Report
2024 Semi-Annual Report Summary
Yaheluon (688575.SH): The net income in the first half of the year was 0.173 billion yuan, a year-on-year increase of 22.25%.
On August 29, ACLON (688575.SH) released its semi-annual report for 2024, achieving operating revenue of 0.96 billion yuan in the first half of the year, a year-on-year decrease of 10.69%; achieving net income attributable to shareholders of the listed company of 0.173 billion yuan, a year-on-year increase of 22.25%; achieving net income attributable to shareholders of the listed company after deducting non-recurring gains and losses of 0.161 billion yuan, a year-on-year increase of 25.85%; and basic earnings per share of 0.3 yuan.
No Data
No Data